Company intelligence / Profile preview

GTSW Bio

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

GTSW Bio is an emerging biotechnology company focused on the discovery and development of innovative therapies for oncology and autoimmune disorders. The company leverages a proprietary platform that integrates structure-based drug design with advanced computational tools to identify novel small molecule and antibody candidates. Currently in the pre-clinical stage, GTSW Bio aims to address significant unmet medical needs by targeting complex biological pathways. The firm is building a pipeline of high-potential programs designed to provide more effective and safer treatment options for patients worldwide.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeAntibody
Industry: Biotech

Beyond the preview

Go deeper on GTSW Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GTSW Bio.

Explore the full profile